XML 21 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statement of Cash Flows
 12 Months Ended
Dec. 31, 2022
USD ($)
Statement of Cash Flows [Abstract]  
Net Decrease in Net Assets from Operations $ (3,927,953)
Adjustments to reconcile net loss to net cash used in operating activities:  
Recognition of conversion of SAFE note liabilities to Common Shares (25,375,657)
Net unrealized depreciation of investments 28,483,048
Purchases of investments (39,778,832)
Return of capital from investments 13,310,000
Net unrealized appreciation on SAFE note liabilities (677,092)
Net unrealized appreciation on warrants (1,441,461)
Changes in operating assets and liabilities:  
Increase in interest receivable (184,250)
Decrease in deferred offering cost payable to Organizer 144,340
Increase in Due to Organzier 204,749
Increase in professional fees payable 40,251
Increase in fund administration fee payable 169,458
Increase in other fees payable 32,653
Decrease in investment fee payable (390,028)
Decrease in management fee payable (933,731)
Increase in payable to Shareholder 75,000
Decrease in payable for investments purchased (6,998,590)
Net cash used in operating activities (37,248,095)
Cash Flows from Financing Activities  
Proceeds from issuance of SAFE notes 2,398,502
Proceeds from issuance of warrants 106,528
Net cash provided by financing activities 2,505,030
Net Decrease in cash (34,743,066)
Cash, beginning of period 46,768,865
Cash, end of period 12,025,800
Non-cash financing activities  
SAFE notes conversion to common stock 64,697,000
Total non-cash financing activities $ 64,697,000